热门资讯> 正文
ALX肿瘤学GAAP每股收益为-0.42美元，相差0.06美元
2026-02-27 21:35
- ALX Oncology press release (ALXO): Q4 GAAP EPS of -$0.42 misses by $0.06.
- Net loss of $22.85M.
More on ALX Oncology
- ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- ALX Oncology Holdings Inc. (ALXO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ALX Oncology jumps on venture capital fund share purchase
- ALX Oncology announces pricing of underwritten offering; shares up nearly 15%
- Seeking Alpha’s Quant Rating on ALX Oncology
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
